| 2017 | 2019 | 2020 (projected) | Accounts Payable | 945 K | 1.2 M | 1.03 M | Receivables | 210 K | 14.95 K | 15.34 K |
Breaking down the current Applied Genetic volatility
 | By Raphi Shpitalnik | Macroaxis Story |
Given the investment horizon of 60 days, Applied Genetic is expected to generate 4.27 times more return on investment than the market. However, the company is 4.27 times more volatile than its market benchmark. It trades about 0.1 of its potential returns per unit of risk. The DOW is currently generating roughly 0.15 per unit of risk. While many risk-averse investors are getting carried away by overanalyzing healthcare space, it is reasonable to go over Applied Genetic. We will cover the possibilities of Applied Genetic's current volatility to continue through October. The current above-average Applied Genetic's volatility may impact the value of the stock as we project Applied Genetic as currently undervalued. The real value, according to our calculations, is approaching 7.88 per share.
Macroaxis uses a strict editorial review process to publish stories and blog posts. Our publishers support our company and may receive a small commission when the partner links or references are utilized. Commissions do not affect the opinions or evaluations of our editorial team. The information our editors and media partners deliver is confidential and licensed for your sole use as a Macroaxis user. We reserve all rights to the content of this article, and therefore copying or distributing this story in whole or in part is strictly prohibited.
Reviewed by Ellen Johnson
This firm currently holds 5.48 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest Applied Genetic is not taking enough advantage from borrowing. The company has a current ratio of 6.32, suggesting that it is liquid enough and is able to pay its financial obligations when due. Volatility is a rate at which the price of Applied Genetic or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Applied Genetic may increase or decrease. In other words, similar to Applied's beta indicator, it measures the risk of Applied Genetic and helps estimate the fluctuations that may happen in a short period of time. So if prices of Applied Genetic fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our technical analysis page.
Watch out for price decline
Please consider monitoring Applied Genetic on a daily basis if you are holding a position in it. Applied Genetic is trading at a penny-stock level, and the possibility of delisting is much higher compared to other delisted stocks. However, just because the stock is trading under one dollar, does not mean it will be marked for deletion. Most exchanges require public instruments, such as Applied Genetic stock to be traded above the $1 level to remain listed. If Applied Genetic stock price falls below $1 for 30 consecutive trading days, the exchange can delist it. Once the company reaches this point, they will be sent an initial price violation notice directly from an exchange.
How important is Applied Genetic's Liquidity
Applied Genetic financial leverage refers to using borrowed capital as a funding source to finance Applied Genetic ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Applied Genetic financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Financial leverage can amplify the potential profits to Applied Genetic's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Applied Genetic's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets). Please check the breakdown between Applied Genetic's total debt and its cash.
Detailed Perspective On Applied Genetic
Applied Genetic Tech reported the previous year's revenue of 2.86 M. Net Loss for the year was (41.9 M) with profit before overhead, payroll, taxes, and interest of 27.86 M.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Applied Genetic. Please refer to our Terms of Use for any information regarding our disclosure principles.